Five Pharmaceutical Stocks That Outperformed the Sector Since Last Diwali

Recent market developments, such as the semaglutide patent expiration in India and evolving US drug tariffs, have significantly influenced pharmaceutical sector investments. Despite regulatory shifts and growing CDMO opportunities, select pharma stocks managed to outperform the broader sectoral index over the past year. This stellar performance highlights the resilience and high-growth potential of these specific market players within the healthcare industry.